Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells*
暂无分享,去创建一个
C. Klinge | Y. Teng | R. Prough | M. Doll | D. Hein | Margarita M. Ivanova | Brandie N. Radde | L. Litchfield | B. Clark | Margarita M Ivanova
[1] Xiuping Liu,et al. Regulation of the Extrinsic Apoptotic Pathway by MicroRNA-21 in Alcoholic Liver Injury* , 2014, The Journal of Biological Chemistry.
[2] C. Klinge,et al. Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor , 2014, Molecular and Cellular Endocrinology.
[3] Jie Shen,et al. Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma , 2014, Cancer Cell International.
[4] E. Prossnitz,et al. Estrogen biology: New insights into GPER function and clinical opportunities , 2014, Molecular and Cellular Endocrinology.
[5] P. Pontisso,et al. MicroRNAs and SerpinB3 in hepatocellular carcinoma. , 2014, Life sciences.
[6] Xintian Zhang,et al. ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells , 2014, PloS one.
[7] J. Gustafsson,et al. Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS. , 2013, Journal of molecular endocrinology.
[8] G. Reynolds,et al. Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice , 2013, Endocrinology.
[9] N. Samaras,et al. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? , 2013, Rejuvenation research.
[10] C. Stournaras,et al. Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors. , 2013, Endocrinology.
[11] Lei Zhu,et al. Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma , 2013, PloS one.
[12] Sheng Lin,et al. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma. , 2013, Cancer research.
[13] K. Fukunaga,et al. Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice , 2013, PloS one.
[14] Yasuhiro Nakamura,et al. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. , 2013, The Journal of clinical endocrinology and metabolism.
[15] D. Sisci,et al. G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17β-Estradiol in Cancer Cells and Cancer-associated Fibroblasts* , 2012, The Journal of Biological Chemistry.
[16] M. Tevfik Dorak,et al. Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue , 2012, Front. Gene..
[17] Yuanyuan Wu,et al. Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)* , 2012, The Journal of Biological Chemistry.
[18] George Notas,et al. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach , 2012, Steroids.
[19] P. Linsley,et al. Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver. , 2012, RNA.
[20] T. Tamaki,et al. Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes , 2012, PloS one.
[21] P. Jansen,et al. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. , 2012, Journal of hepatology.
[22] Zhiming Wang,et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. , 2012, Oncology reports.
[23] P. Thomas,et al. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. , 2012, Endocrinology.
[24] O. Hennebert,et al. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines , 2012, Steroids.
[25] S. Flament,et al. Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction , 2012, Molecular and Cellular Endocrinology.
[26] R. Girgert,et al. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy , 2012, Breast Cancer Research and Treatment.
[27] Zhaoyu Li,et al. Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer , 2012, Cell.
[28] B. Boyan,et al. Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)* , 2012, The Journal of Biological Chemistry.
[29] Richa Tiwary,et al. Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer , 2011, Breast Cancer Research.
[30] A. Traish,et al. Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. , 2011, The journal of sexual medicine.
[31] Laura Beretta,et al. Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease , 2011, PloS one.
[32] E. Prossnitz,et al. The G-protein-coupled estrogen receptor GPER in health and disease , 2011, Nature Reviews Endocrinology.
[33] Xuehao Wang,et al. miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males , 2011, Clinical Cancer Research.
[34] Heike Allgayer,et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. , 2011, Bioscience reports.
[35] G. Carruba,et al. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. , 2011, Omics : a journal of integrative biology.
[36] Dalei Wu,et al. FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. , 2011, Biochimica et biophysica acta.
[37] M. Albitar,et al. Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.
[38] G. Goodall,et al. Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells , 2010, The Journal of Biological Chemistry.
[39] M. Maggiolini,et al. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.
[40] Y. Hung,et al. Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription , 2010, Science Translational Medicine.
[41] Terence P. Speed,et al. Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes* , 2010, The Journal of Biological Chemistry.
[42] Yan Xie,et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. , 2010, Molecular endocrinology.
[43] S. Ho,et al. Activation of GPR30 inhibits growth of prostate cancer cells via sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest , 2010, Cell Death and Differentiation.
[44] P. Leung,et al. Gonadotropin-releasing hormone-mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse gonadotrophs. , 2009, Endocrinology.
[45] E. Prossnitz,et al. Mechanisms of estrogen signaling and gene expression via GPR30 , 2009, Molecular and Cellular Endocrinology.
[46] Tudor I. Oprea,et al. In vivo Effects of a GPR30 Antagonist , 2009, Nature chemical biology.
[47] Megan Coleman,et al. Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36 , 2009, FEBS letters.
[48] N. Colburn,et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.
[49] J. Wen,et al. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. , 2008, Molecular endocrinology.
[50] Sun Hee Jin,et al. Methyl-β-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK , 2008, Archives of Dermatological Research.
[51] Shuji Fujita,et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. , 2008, Journal of molecular biology.
[52] C. Klinge,et al. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. , 2008, Molecular endocrinology.
[53] John H. White,et al. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.
[54] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[55] C. Klinge,et al. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells. , 2006, Cancer research.
[56] H. Zhang,et al. Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.
[57] T. Simoncini,et al. Estrogen Receptor α Interacts with Gα13 to Drive Actin Remodeling and Endothelial Cell Migration via the RhoA/Rho Kinase/Moesin Pathway , 2006 .
[58] Tudor I. Oprea,et al. Virtual and biomolecular screening converge on a selective agonist for GPR30 , 2006, Nature chemical biology.
[59] N. Avlonitis,et al. G protein‐associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] R. Prough,et al. The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors , 2006, Drug metabolism reviews.
[61] D. Mayer,et al. Impact of dehydroepiandrosterone on hepatocarcinogenesis in the rat (Review). , 2004, International journal of oncology.
[62] B. P. Ceresa,et al. Continual Expression of Rab5(Q79L) Causes a Ligand‐Independent EGFR Internalization and Diminishes EGFR Activity , 2004, Traffic.
[63] Dongmin Liu,et al. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor , 2004, Steroids.
[64] J. Marks,et al. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[65] R. V. van Etten,et al. Modulation of hepatic acute phase gene expression by epidermal growth factor and src protein tyrosine kinases in murine and human hepatic cells , 1999, Hepatology.
[66] B. Deurs,et al. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. , 1999, Molecular biology of the cell.
[67] D. Lannigan,et al. Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.
[68] J. Goméz,et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. , 1997, The Journal of clinical endocrinology and metabolism.
[69] H. Olivier,et al. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines. , 2012, Steroids.
[70] H. Ho,et al. Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. , 2008, International journal of oncology.
[71] B. Wilson,et al. Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. , 2007, Neoplasia.
[72] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.